Beijing Suncadia Pharmaceuticals Co., Ltd

This study tested a new medicine called SHR-1918 in 26 people with a rare genetic condition that causes extremely high cholesterol (homozygous familial hypercholesterolemia). The main goal was to see if the drug could lower their bad cholesterol levels after 12 weeks. All partici…

This study tested a new medicine called SHR-1918, given as a shot under the skin, in people with high cholesterol that was not well controlled by their current statin therapy. About 335 adults took part. The goal was to see if adding SHR-1918 to their usual cholesterol-lowering d…

This study tested a new medicine called SHR-1918, given as multiple shots under the skin, in 44 adults with high cholesterol that was not well controlled by current treatments. The goal was to see if it safely lowers 'bad' LDL cholesterol over 24 weeks. This is a phase 2 trial, m…

This study tested a new medicine called SHR-1918 in 55 people with homozygous familial hypercholesterolemia (HoFH), a rare genetic condition causing very high cholesterol. The goal was to see if the drug could safely lower bad cholesterol levels. Participants received either the …

This study tested a new medicine called SHR-2004 to see if it can prevent dangerous blood clots in the legs or lungs after knee replacement surgery. Over 1,100 adults who were scheduled for knee replacement took part. The goal was to compare how well SHR-2004 works and how safe i…

This early-stage study tested the safety and tolerability of a new drug called HRS-8829 in 83 healthy adults aged 18 to 55. The study used a placebo-controlled, dose-escalation design to see how the body handles the drug and to check for side effects. The goal was to gather safet…